Cargando…
Identification of tumor‐associated macrophage subsets that are associated with breast cancer prognosis
BACKGROUND: Breast cancer is the leading cause of cancer‐related deaths in women, demanding new treatment options. With the advent of immune checkpoint blockade, immunotherapy emerged as a treatment option. In addition to lymphocytes, tumor‐associated macrophages exert a significant, albeit controve...
Autores principales: | Strack, Elisabeth, Rolfe, P. Alexander, Fink, Annika F., Bankov, Katrin, Schmid, Tobias, Solbach, Christine, Savai, Rajkumar, Sha, Weixiao, Pradel, Leon, Hartmann, Sylvia, Brüne, Bernhard, Weigert, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719284/ https://www.ncbi.nlm.nih.gov/pubmed/33377644 http://dx.doi.org/10.1002/ctm2.239 |
Ejemplares similares
-
Phenotypic Plasticity of Fibroblasts during Mammary Carcinoma Development
por: Elwakeel, Eiman, et al.
Publicado: (2019) -
Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy
por: Zheng, Xiang, et al.
Publicado: (2017) -
Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype
por: Frank, Ann-Christin, et al.
Publicado: (2019) -
Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer
por: Sarode, Poonam, et al.
Publicado: (2020) -
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
por: Weichand, Benjamin, et al.
Publicado: (2017)